RIGL — RIGEL PHARMACEUTICALS INC

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1034842 ·
Last close
$42.92
Market Cap
$808.18M
52W High
$52.61
52W Low
$24.95
ADV30
237,556
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 80,890,000 70,107,000 17,105,000 13,185,000 523,877,000 46,646,000 78,770,000
Jun 2026 78,703,000 70,178,000 23,575,000 17,290,000 521,066,000 60,816,000 95,644,000
Mar 2026 58,818,000 54,212,000 11,885,000 8,654,000 504,608,000 24,411,000 104,711,000
Dec 2025 69,802,000 63,847,000 23,170,000 268,065,000 513,594,000 40,580,000 122,114,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$79,389,000
Investing CF
$-49,059,000
Financing CF
$-22,921,000
CapEx
—
Dividends Paid
—
Buybacks
$-4,251,000
EPS Diluted TTM
$16.32
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-997,097,000
Inventory
$14,367,000
Receivables
$56,041,000
ST Investments
$34,513,000
EBIT TTM
$91,381,000
Pretax Income TTM
$85,576,000
Interest Exp TTM
$5,805,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$288,212,992
EBITDA
$79,574,000
Free Cash Flow
$-13,774,625
Enterprise Value
$655,095,360
Total Cash
$99,305,000
Total Debt
$7,792,000
Shares Out
18,829,972
Trailing EPS
$16.07
Book Value
$23.64
ROE
109.2%
ROA
12.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 294,282,000 125,466,000 367,024,000 513,594,000 122,114,000 391,480,000 75,655,000
Dec 2024 179,278,000 24,192,000 17,485,000 163,976,000 160,688,000 3,288,000 31,471,000
Dec 2023 116,882,000 -20,491,000 -25,091,000 117,225,000 145,869,000 -28,644,000 -5,743,000
Dec 2022 120,242,000 -54,230,000 -58,573,000 134,279,000 147,895,000 -13,616,000 -73,758,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$276,785,000
NetIncome TTM
$321,909,000
OpCashFlow TTM
—
Assets (Latest)
$521,066,000
Forward EPS
$4.94

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $35.00 · spot: $42.53 · call volume: 218 · put volume: 103

Peers — same industry

TickerNameMarket CapLastDaily %
IRWD IRONWOOD PHARMACEUTICALS INC $806.23M $4.87 —
ARDX ARDELYX, INC. $799.36M $3.18 —
COLL COLLEGIUM PHARMACEUTICAL, INC $793.98M $25.55 —
LXRX LEXICON PHARMACEUTICALS, INC. $792.52M $1.78 —
SNDX Syndax Pharmaceuticals Inc $828.26M $9.20 —

News headlines (Yahoo Finance, 1h cache)

Rigel to Present at the Jefferies Global Healthcare Conference in London
2026-11-10 13:05 · Yahoo
Rigel Pharmaceuticals Q3 Earnings Call Highlights
2026-11-06 19:14 · Yahoo
Rigel Pharmaceuticals Inc (RIGL) (Q3 2026) Earnings Call Highlights: Record Product Sales of ...
2026-11-06 19:14 · Yahoo
Rigel (RIGL) Q3 2026 Earnings Call Transcript
2026-11-06 06:13 · Yahoo
Rigel Pharmaceuticals (RIGL) Misses Q3 Earnings Estimates
2026-11-06 00:00 · Yahoo
Rigel: Q3 Earnings Snapshot
2026-11-05 23:03 · Yahoo
Rigel Announces Oral Presentation of Phase 1b Data for R289 in Patients with Lower-Risk MDS at the 68th American Society of Hematology Annual Meeting and Exposition
2026-11-04 14:15 · Yahoo
Rigel Announces Conference Call and Webcast to Report Third Quarter 2026 Financial Results
2026-10-29 12:05 · Yahoo
Rigel Highlights New GAVRETO® (pralsetinib) Data Across RET Fusion-Positive Cancers in Oral and Poster Presentations at ESMO Congress 2026
2026-10-19 12:05 · Yahoo
Rigel Pharmaceuticals (RIGL) Stock Sees Fair Value Lift As Veppanu Launch Adds Growth Hope
2026-08-16 05:08 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.